Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-27

Clinical Trial Update: Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease [Phase 2]

View source ↗

Summary

Phase 2 pediatric trial evaluating the impact of Vitamin D therapy on thyroid function and antibody levels in Graves' disease; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Northwell Health | Conditions: Graves Disease, Graves' Disease | Phase 2 | Status: RECRUITING